Next Article in Journal
An Overview of the Biological Activity of Pyrrolo[3,4-c]pyridine Derivatives
Next Article in Special Issue
Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study
Previous Article in Journal
Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion
Previous Article in Special Issue
Budget Impact Analysis of Biosimilar Products in Spain in the Period 2009–2019
 
 
Commentary

Article Versions Notes

Pharmaceuticals 2021, 14(4), 352; https://doi.org/10.3390/ph14040352
Action Date Notes Link
article xml file uploaded 10 April 2021 11:07 CEST Original file -
article xml uploaded. 10 April 2021 11:07 CEST Update -
article pdf uploaded. 10 April 2021 11:07 CEST Version of Record https://www.mdpi.com/1424-8247/14/4/352/pdf-vor
article html file updated 10 April 2021 11:09 CEST Original file -
article xml file uploaded 14 April 2021 12:54 CEST Update -
article xml uploaded. 14 April 2021 12:54 CEST Update -
article pdf uploaded. 14 April 2021 12:54 CEST Updated version of record https://www.mdpi.com/1424-8247/14/4/352/pdf-vor
article html file updated 14 April 2021 12:55 CEST Update -
article xml file uploaded 21 April 2021 09:49 CEST Update -
article xml uploaded. 21 April 2021 09:49 CEST Update https://www.mdpi.com/1424-8247/14/4/352/xml
article pdf uploaded. 21 April 2021 09:49 CEST Updated version of record https://www.mdpi.com/1424-8247/14/4/352/pdf
article html file updated 21 April 2021 09:50 CEST Update -
article html file updated 4 August 2021 22:34 CEST Update -
article html file updated 25 July 2022 11:37 CEST Update https://www.mdpi.com/1424-8247/14/4/352/html
Back to TopTop